Okay, let's tackle this question. The user provided a question about Hypertrophic Obstructive Cardiomyopathy (HOCM) asking which statement is not true. The correct answer is missing, so I need to figure out what the options might be. Since the options are labeled A to D but not listed, I'll have to infer based on common misconceptions about HOCM.

First, the core concept: HOCM is a genetic disorder characterized by abnormal thickening of the heart muscle, especially the interventricular septum. This leads to left ventricular outflow tract obstruction. It's often associated with a systolic ejection click and a harsh systolic murmur that can radiate to the carotids. It's also linked to sudden cardiac death in young athletes.

Now, the correct answer is the one that's false. Let's think of typical incorrect statements. For example, HOCM is not caused by a deficiency in a specific enzyme like in some metabolic disorders. It's usually due to mutations in sarcomeric proteins, like myosin. Another common mistake is thinking that beta-blockers are contraindicated, but they're actually used to reduce outflow obstruction by decreasing contractility.

Wrong options might include things like "HOCM is associated with left ventricular dilation" (it's actually hypertrophy), "caused by excess catecholamines" (it's genetic), or "treated with diuretics" (they can worsen preload and increase obstruction).

Clinical pearls: Remember that HOCM is an autosomal dominant condition. Beta-blockers and calcium channel blockers are mainstays. Avoid vasodilators and positive inotropics as they can worsen the obstruction.

Putting it all together, the explanation should highlight the correct mechanisms and why the incorrect options are wrong, focusing on the key aspects of the disease.

**Core Concept**
Hypertrophic obstructive cardiomyopathy (HOCM) is an autosomal dominant genetic disorder caused by mutations in sarcomeric proteins (e.g., β-myosin heavy chain, troponin T). It features asymmetric left ventricular hypertrophy, dynamic outflow tract obstruction, and diastolic dysfunction. Key clinical features include a systolic ejection murmur, dynamic obstruction, and risk of arrhythmogenic sudden cardiac death.

**Why the Correct Answer is Right**
The false statement is typically one that mischaracterizes the pathophysiology or management. For example, a common incorrect claim is that HOCM is caused by *excess catecholamines* (it’s genetic, not neurohumoral). Alternatively, a false statement might assert that *diuretics are first-line therapy* (they reduce preload, worsening outflow obstruction). Correct management includes β-blockers or nondihydropyridine calcium channel blockers to reduce contractility and minimize dynamic obstruction.

**Why Each Wrong Option is Incorrect**
**Option A:** *If it claims HOCM is caused by a sarcomere mutation* — this is correct. Mutations in sarcomeric proteins (e.g., MYH7, TNNT2) are the primary pathogenesis.
**Option B:** *If it states the murmur increases with squatting* — this is incorrect. The murmur intensifies with maneuvers that reduce left ventricular volume (e.g., standing

✓ Correct Answer: A. β agonists are useful